₦airaland Forum

Welcome, Guest: RegisterLoginWith GoogleTrendingRecentNew

Stats: 3,325,311 members, 8,421,286 topics. Date: Saturday, 06 June 2026 at 08:08 AM

Toggle theme

SohSoh's Posts

Nairaland ForumSohSoh's ProfileSohSoh's Posts

1 2 3 4 5 6 (of 6 pages)

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh:
...
InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 7:33pm On Jul 12, 2025
I'm going to share two set of information with you and I believe without proper investigation you and chat GPT would have said the companies were legit

1:: EFishery an Indonesian Agricultural Company

Link :: A TikTok Clip by Bloomberg ::: https://vt.tiktok.com/ZSBX9Pbkw/
Picture also attached

2: Tingo Food or Tingo Group by dozy mmobuosi
Picture also attached read about it

My opinion:: people in Nigeria fell for CBEX and if someone is being scammed and you tried to correct they they will you names


benzmatic:
https://openai.com/chatgpt/overview/ Is Ellah Lakes a scam company?

Ellah Lakes Plc is a **publicly listed agribusiness** on the Nigerian Exchange (NGX), founded in 1980, with a focus on oil palm, cassava, soybean, rice, maize and livestock. It’s a legitimate company with ongoing partnerships, government projects, and a public track record—not a scam. Here’s what recent reporting shows:

---

### ✅ Confirmed activities & credibility

* In **September 2022**, Ellah Lakes took over the management of the 5,000-hectare Adarice Farms in Enugu State under a Memorandum of Understanding with the state government, aiming to build a “Staple Crop Processing Zone” ([Nairametrics][1], [Nairametrics][2]).
* It also has a 2,400-hectare palm plantation acquired in 2019 and is working on additional 5,000-hectare leases in Ondo and Enugu ([Nairametrics][3]).
* The company has registered capital raises and funding rounds, including a ₦5 billion private placement in early 2024 and previous funding efforts including rights issues and partnerships .

### 📉 Financial lens

* Ellah Lakes has faced **financial challenges**, including periods of zero or minimal revenue, such as ₦780,000 in 2024 with a net loss of ₦893.9 million ([Businessday NG][4]).
* It is actively restructuring finances—converting debt to equity, issuing new shares, and leveraging government schemes .

### 🌱 Business growth & legitimacy

* The company’s strategy includes vertical integration: crop cultivation + processing, livestock (piggery), and partnerships like the International Institute of Tropical Agriculture (IITA) for soybean production ([The Nation Newspaper][5]).
* Their annual general meetings are well-documented in credible Nigerian media (e.g., BusinessDay, The Guardian, Nairametrics), with executive names published and board activity openly reported ([Businessday NG][4]).

---

### 🚫 Conclusion

Ellah Lakes is a **real, regulated company** with transparency through NGX filings, strategic acquisitions, public-private MOUs, and ongoing expansion plans. While it does face typical agribusiness financial hurdles, there’s **no credible evidence** to suggest it’s a scam. Its operations and public record support its legitimacy.

---

If you’re considering **investing or partnering** with them, I recommend:

* Reviewing their **latest financial statements** on NGX or their investor relations portal.
* Monitoring **ongoing updates around project commissioning** (e.g., palm oil mill activity due in Q1–Q2 2025) ([Businessday NG][4]).
* Seeking professional advice if you’re planning significant involvement.

Let me know if you'd like help digging into their latest annual report, stock performance, or strategic plans!

[1]: https://nairametrics.com/2022/09/12/ellah-lakes-plc-announces-take-over-of-adarice-farms-associated-assets-from-enugu-state-government/?utm_source=chatgpt.com "Ellah Lakes Plc announces Take Over of Adarice Farms & Associated Assets From Enugu State Government - Nairametrics"
[2]: https://nairametrics.com/2022/09/09/ellah-lakes-takes-over-adarice-farms-from-enugu-state-government/?utm_source=chatgpt.com "Ellah Lakes takes over operations of Adarice Farms from Enugu State Government - Nairametrics"
[3]: https://nairametrics.com/2022/09/18/ellah-lakes-plc-making-success-from-refocusing-strategic-acquisitions-under-chuka-mordi/?utm_source=chatgpt.com "Ellah Lakes Plc: Making success from refocusing, strategic acquisitions under Chuka Mordi - Nairametrics"
[4]: https://businessday.ng/companies/article/ellah-lakes-eyes-palm-oil-production-in-2025/?utm_source=chatgpt.com "Ellah Lakes eyes palm oil production in 2025 - Businessday NG"
[5]: https://thenationonlineng.net/ellah-lakes-iita-partner-on-n360b-soybean-market/?utm_source=chatgpt.com "Ellah Lakes, IITA partner on N360b soybean market - The Nation Newspaper"

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 7:21pm On Jul 12, 2025
The same compnay that took loan from FCMB in 2022/2023 and couldnt reply back and converted the loan to euqity ... they can't issue Commercial Paper because they will have poor rating

emmaodet:
Why commercial paper? You raise CP for working capital payable less than a year.. mostly 270 days.
You need capital for many reasons and a short term capital raise is not suitable for long term repayment method.
Why go for CP when you can go for bank long term loan like 5 years?
And why go for bank long term 5 years that would be breathing down on you to payback interest with principal monthly while you can raise the same capital via equity with less pressure.
The aim and objectives of capital use determine which route you will use to raise cash.
InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 7:16pm On Jul 12, 2025
My partner my friend im sorry we are in the same boat together ... one cold beer for you grin grin grin
Streetinvestor2:
Nop I just wanted to confirm. I don't even know anything about the company. Infact na from you I dey hear about the company for the first time.
Looks you don't know .I am worst enemy of the people marketing that junk stock called ellahlakes on this thread. They may accuse me of sending you to spoil thr market on the company..lol
InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 7:15pm On Jul 12, 2025
I didn't include MECURE in the list cos it only gave me about 10% captial appreciation also didn't include AIICO in the list too cos it gave me about 10-15% captial appreciation as of the time i posted or made the list. the stocks on the list are my winners... (30-100% capital appreciation) and to be honest I already brought MECURE before I even came here to promote it..

Panadee:
I recall you also posted your ‘portfolio’ a few days ago while complaining about ‘hypocrisy’ and that people didn’t buy MECURE.
The funny thing is that I couldn’t find the same MECURE in your list of stocks. Was that an omission? grin

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 4:55pm On Jul 12, 2025
What r u talking about... i gave Mecure as a buy recommendation few weeks ago. Or you want to say Mecure is a scam company like Ellah Lakes


Streetinvestor2:
Bros you go soon put me for wahala. They go soon say na me send you come.Nobe you come last time to market one phem stock abi I am mistaking u for another moniker .The name na legend. Na thr I firt hear the name of the company
InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 4:34pm On Jul 12, 2025
Ellah Lakes Ellah Lakes grin grin grin

As seen on nairametrics

1: in year September 2022 : took over Adarice Farms from Enugu state government, no pictures of the Rice in the Market, but in 2024 & 2023 declared zero revenue

2: September 2022, claimed to make acquisitions, yet those companies acquired in 2023 & 2024 made zero revenue

3: September 2023 , Got SEC approval to raise 2.9billion yet in 2023 $ 2024 made zero revenue

4: October 2023 plans to invest 400million usd… yet in same 2023, and 2024 made zero revenue

No be juju be that

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 3:52pm On Jul 12, 2025
Did you read this news article ... a company can couldn't repay or manage 940 million loan... is seeking 250billion

They should issue commercial paper least see if they can repay since company like Dangote, Fidson, Mecure industries are all issuing commercial paper Ellah Lakes should issue commercial paper ....



Princkez:
don't worry about the new investor because the money is already down...please wait till after the egm .

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 3:15pm On Jul 12, 2025
#EllahLakes

I can't upload the TikTok Video from Bloomberg

#EllahLakes

Link Attached another Agricultural company that sent fake number is to investors
TikTok Link By Bloomberg ::: https://vt.tiktok.com/ZSBX9Pbkw/


Now the same Ellah Lakes wants to raise 250 billion same compnay with Zero revenuefor 2 consecutive years .. na Loco,Megawealth and Street Investor go buy am grin grin grin

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 11:47am On Jul 12, 2025
July 14 is on Monday ..... market should reward banks that have met this recapitalization or banks that submit a good steady plan ... lol 😆

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 10:14am On Jul 11, 2025
BLOCKED!!!!!

crownprince2017:
On the street, the name sohsoh means
"omo Ase"
If you are, we are not.
grin grin grin grin
InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 10:13am On Jul 11, 2025
Using Tingo Foods as my example

1: Google to and search " Tingo Foods" looks at the videos section the dozy guy did interview and stake holders meeting

2: why aren't there pictures of Ellah Lake produces on the internet, if the company produces any thing surely the pictures would have made it to the internet, no pictures of equipment or asset used by the company..

Even Lagos State wey they produce RICE the picture of the rice plenty for internet



crownprince2017:
For your mind now, you think you are smart, I don't think so, were you not alive when someone like u organise a Q&A session with the CEO? Let say u were not wise enough to come n ask the questions disturbing your mind atleast he gave the address of the farm which you can listen to online with 500 data.

You would have make a lot of sense saying you went to the farm and discovered everything said by the CEO is lie. Hence, you can establish the tinko guy relationship.

Logically, you guys are contradicting each other based on tinko comparisons.

Ellahlakes gave the complete address where the operations are taking place did tinko do that? Instead u were carried away by tinko big packaged office.

Did tinko guy grant interview that allow shareholders ask questions?

The Lake Rice in the pictures is not produced by Ellah Lakes

Why aren't there any pictures of the Ellah Lake Products on the internet?

You are a joke... grin grin grin grin grin grin

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 2:56am On Jul 11, 2025
Ellah Lakes might be a scam or phony company

All the pictures of ellah lakes on the internet are digital, and not real, there are no pictures or videos of or from the business operations or behind the scenes, assets or equipments, used by the company.
Using dangote Refinery as an example we have seen pictures and videos of and from the refinery.

Cutix I've seen there product in the market.

Also in 2020 Ellah Lakes had zero revenue ... the company might be a scam...

and before alot of you are quick to argue... there is the case of " Dozy Mmobuosi " (read about it) of " Tingo Foods" that faked a company like Ellah Lake and listed it on NYSE

Ellah Lake might be a phony company or scam company ....

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh:
I want to get this off my mind…to some extent a lot of you on this forum are hypocrites.

Few weeks ago I wrote a buy recommendation for MECURE as a better BUY than FIDSON AND NEIMETH as of that time

and shared it here the same way Loco does and a vast majority of the people here shut it down and said Fidson was a better option and went and pushed the price of FIDSON up Price above MECURE, if that was to taunt me, I don’t care

Few days back i saw a lot of you are now recommending NEIMETH the books ain’t good.

So I came to the conclusion that a lot of you here are institutional traders and not retail traders like ME…

Cos a lot of the information LOCO shares are not easily available on the internet
And was already posting about EllahLakes long before the CEO did that interview… just be careful cos it looks a lot like insider trading and the ship post about C&I Leasing that also is not available to retail investors or traders like me self.


Why I’m writing all thesehuh? is because if you guys here were, welcoming maybe I would have tried more to share some of my trade ideas because when I buy a stock I don’t come here to try and promote it for it too move


Now this is my trade over the last 3 months… (PICTURE ATTACHED)

While LOCO is only promoting Champion, C&I Leasing, EllahLakes : by my calculations: LOCO has made 495% profit increase in his trade with these 3 stocks with a lot of promotion

And
ME : 531% ( picture attached my BUY prices)

I didn't include Champion cos I brought Champion long before he started promoting it here

And there are stocks I brought that gave me 15-20% ( like AIICO, Aradel and Legend internet)

So my 530% should be close to 600-700%

No Promotion just Good Trading!!

Drops Mic !!

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 6:15am On Jun 03, 2025
grin grin grin grin grin grin

SonofElElyonRet:
You want a list ?
InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 2:58am On Jun 03, 2025
Your analysis is sharp and well-structured, it demonstrates a clear understanding of valuation metrics, earnings quality, and risk-reward tradeoffs.

That said, I remain confident in my BUY recommendation on MeCure. While I respect your view that Fidson may offer stronger fundamentals at this time.

it’s a free market, and that’s the beauty of it. Differing views, based on distinct strategies and time horizons, are what make markets function.

now :: I'm a trader, just looking for my next take profit, if the stock goes up fine I'll take my profit and walk away, if it goes down, I'll take my loss and walk away, but so far my analysis, that I have used previously has allowed me to take trades like this.

""" explanation to the photos attached """

1: my entry price for custodian was @18.10 on 15 may 2025, and on17 May.
Nairametrics released that article as to why custodian might be undervalued, fast forward to 6 days ago, the CEO of Toyota brought 150Mn shares at 3Bn.
and recently, custodian was among the stock recommendation from Morgan capital.

All these i consider catalyst to cause the price to move up ward.


2: my buy and sell entry for UPL
3: My entry for champion, which crossed well over 100% return, I'm not an investor, looking to buy and hold for the next 2/3 years like someone said about CUTIX. I'm just looking for my next take profit.



bovali:
Mecure Key Financials (Q1 2025)
- Profit After Tax (Q1 2025): ₦568.71 million
- Basic EPS (Q1 2025): ₦0.14 per share
- Shares Outstanding: 4,000,000,000
- Annualized EPS: ₦0.14 x 4 = ₦0.56 per share
- Total Equity (March 2025): ₦14,527,713,000
- Book Value Per Share: ₦14,527,713,000 / 4,000,000,000 = ₦3.63 per share

Valuation
1. P/E Multiple (Nigerian Pharma: 8x–12x)
P/E - Implied Value (₦)
8x - 0.56 x 8 = 4.48
10x - 0.56 x 10 = 5.60
12x - 0.56 x 12 = 6.72

2. Price/Book (P/B) Method
- Book Value Per Share: ₦3.63
- P/B Range (1.0x–1.5x): ₦3.63 – ₦5.45

Fidson Key Financials (Q1 2025)
- Profit After Tax (Q1 2025): ₦3,250,658,000
- Basic EPS (Q1 2025): 142 kobo = ₦1.42
- Shares Outstanding: 2,294,996,000 shares
- Annualized EPS: ₦1.42 x 4 = ₦5.68
- Total Equity (March 2025): ₦26,976,971,000
- Book Value per Share: ₦26,976,971,000 / 2,294,996,000 ≈ ₦11.76 per share

Valuation
1. P/E Multiple (Sector Range: 6x–10x)
P/E - Implied Fair Value (₦)
6x - 5.68 x 6 = 34.08
8x - 5.68 x 8 = 45.44
10x - 5.68 x 10 = 56.80

2. Price/Book (P/B) Method
- Book Value per Share: ₦11.76
- P/B Range (1x–1.5x): ₦11.76 – ₦17.64

My Opinion
- I intentionally used a lower multiple for Fidson just to show why it is fundamentally stronger than MeCure on both earnings and asset base.
- The market should and does price Fidson at a premium to MeCure, justified by higher profit, superior balance sheet, and a track record of sector leadership.
- If you are considering both as portfolio candidates, Fidson offers better downside protection (via asset base) and greater upside if sector multiples expand.
- MeCure remains investable at the lower band of sector multiples, especially if its cancer center and recent projects drive sustainable profit growth, but it is a “mid-tier” play versus Fidson’s “sector leader” status. Mecure is overvalued as it is. Best case it goes to 14 naira (26% upside) or it drops to 7 naira (37% down side)

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 11:43pm On Jun 02, 2025
WHO IS PAYING BIG DIVIDENDS LATELY, EVEN Champion breweries THAT MADE 21 BILLION IN EARNINGS AND 900MILLION + PROFIT ONLY PAID ABOUT 6KOBO

megawealth01:
But their dividends paymet is very low na
InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 11:39pm On Jun 02, 2025
AGAIN YOU GUYS ARE FAILING TO SEE THE POINT, MECURE INDUSTRIES PLC " CURRENTLY " IS A BETTER BUY THAN FIDSON,
WHICH IS WHY I'M RECOMENDING IT AS A CURRENT BUY RECOMMENDATION.

Sunrisepebble:
English grin
Fidson looks the better stock in that sector. Paid N1 from 2.something earnings. They can likely pay N2 for the next full year
InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 7:13pm On Jun 02, 2025
my " BUY " recommendation on MeCure Industries Plc is based on a combination of strong fundamentals and prudent financial management. Despite the repayment of a significant portion of their commercial paper obligations, the company has remained profitable, posting a ₦568.71 million net profit in Q1 2025 and delivering 65% year-on-year revenue growth.

This reflects a resilient business model, disciplined capital allocation, and a management team that has demonstrated both operational efficiency and strategic foresight. The company's ability to grow earnings while meeting debt obligations is a key indicator of underlying strength—not just good management, but effective execution.

megawealth01:
The MECURE guy here... What exactly do you see in this MECURE that makes you declare it a buy RECOMMENDATION?

All I can see about them is they probably have good management and predominantly Indians?
InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 3:13am On Jun 02, 2025
Locotrader:
Chief Driver of profitability in Cileasing
Reduction of operation cost by adopting CNG conversion of it's fleets of vehicles in Nigeria through Bola Ahmed Tinubu CNG initiatives and the use of Electric vehicles in Ghana .

The commercial papers of 10B for these initiatives was oversubscribed in March 2025

Read more

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 8:08pm On Jun 01, 2025
Here


Date : June 1 2025

MECURE INDUSTRIES : Q1 Result : As At 31 March 2025.

Link :: https://africanfinancials.com/document/ng-mecure-2025-ir-q1/

Google Search Word : mecure industries 2025


megawealth01:
What about this MECURE you have been posting for days nowhuh

I will look into their books this JUNE when I have free time

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 8:02pm On Jun 01, 2025
Date : June 1 2025

MECURE INDUSTRIES : Q1 Result : As At 31 March 2025.

Link :: https://africanfinancials.com/document/ng-mecure-2025-ir-q1/

Google Search Word : mecure industries 2025

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 11:23am On Jun 01, 2025
DATE : 1 JUNE 2025
Mecure Industries Plc — BUY Recommendation Summary

Executive Overview:

Mecure Industries Plc delivered an impressive financial performance in FY 2024/2025, signaling strong operational execution and growth momentum:

Revenue surged by 45% year-on-year to ₦46.03 billion.

Profit After Tax (PAT) stood at a solid ₦2.33 billion.

The company is well-positioned for sustainable expansion within Nigeria’s fast-evolving healthcare sector.

Capital & Strategic Moves:

Successfully expanded its Commercial Paper (CP) program from ₦20 billion to ₦40 billion, enabling enhanced flexibility in funding growth initiatives.

Raised over ₦26 billion through CP issuances within 16 months at attractive market rates, reflecting high investor demand.

Demonstrates strong access to capital markets, showcasing disciplined and effective financial management.

Valuation & Financial Metrics:

Price-to-Earnings (P/E) Ratio: ~19.0x, in line with peers in the healthcare and pharmaceutical industry.

Dividend Yield: ~1.35%, with a ₦0.15 dividend per ₦11.10 share, delivering consistent shareholder returns.

Maintains an efficient capital structure, supported by active treasury operations and funding agility.

Key Investment Drivers:

Strong Earnings Momentum: Sustained revenue growth and rising profitability highlight operational strength.

Strategic Capital Deployment: Ongoing CP issuances demonstrate proactive and efficient funding strategies.

Reliable Dividend Payments: Consistent dividend distribution underscores commitment to shareholder value creation.

Healthcare Sector Expansion: Mecure is well-positioned to benefit from increasing local demand, import substitution, and rising health expenditures in Nigeria.

Institutional Investor Confidence: Robust participation in the company’s CP program reflects strong market trust and long-term confidence in its strategy.

Conclusion:

Mecure Industries Plc stands out as a high-quality investment opportunity within Nigeria’s pharmaceutical sector. With solid financials, attractive valuation, dividend income potential, and a clear growth trajectory, it presents a compelling case for investors seeking both value and expansion upside.

We assign a BUY recommendation based on Mecure’s proven performance, strategic capital initiatives, and long-term market potential.

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 11:23pm On May 31, 2025
IF YOU LOOK HERE, AT REVENUE VS PEERS : I PLACED IT ABOVE NEIMETH AND BELOW FIDSON

Heishere:
So after the comparison, you placed Mecure above Fidson because of commercial papers? Hope people are not paying you for this recommendation?

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 11:22pm On May 31, 2025
IF YOU LOOK HERE, AT REVENUE VS PEERS : I PLACED IT ABOVE NEIMETH AND BELOW FIDSON

SohSoh:
Thank you for your comment. To clarify, this is a current BUY recommendation for Mecure Industries Plc,
InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 7:38pm On May 31, 2025
Thank you for your comment. To clarify, this is a current BUY recommendation for Mecure Industries Plc,

GeeKudi:
And he keeps posting the long piece repeatedly. We have seen it already nah cheesy
InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 7:26pm On May 31, 2025
Thank you for your comment. To clarify, this is a current BUY recommendation for Mecure Industries Plc,

Heishere:
So after the comparison, you placed Mecure above Fidson because of commercial papers? Hope people are not paying you for this recommendation?
InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh:
" BUY " RECOMENDATION : MECURE INDUSTRIES

Executive Summary



Mecure Industries Plc has demonstrated resilient financial performance for the fiscal year 2024/2025, underpinned by strong revenue growth, rising operating profitability, consistent commercial paper issuances, and a dividend payout to shareholders. With a year-on-year (YoY) revenue increase of 45% to ₦46.03 billion and a Profit After Tax (PAT) of ₦2.33 billion, the company remains well-positioned for sustainable expansion within Nigeria’s evolving healthcare landscape.



Given its favorable growth indicators, attractive valuation relative to peers, and continued investor confidence via capital market instruments, we recommend a BUY rating for Mecure Industries Plc.



Strategic Developments & Capital Structure



Mecure Industries has shown disciplined financial stewardship through the issuance of Commercial Paper (CP) to fund working capital and expansion needs. The company expanded its CP programme from ₦20 billion to ₦40 billion, demonstrating its creditworthiness and market confidence. Notable CP issuances include:

• Series 4 (April 2025): ₦9 billion at 22.5468% discount (267-day tenor)

• Series 3 (June 2024): ₦6.5 billion at 23.26%

• Series 2 (Feb 2024): ₦6.03 billion at 18.20%

• Series 1 (Dec 2023): ₦5.12 billion at 16.68%



The cumulative issuance of over ₦26 billion within a 16-month period reinforces the company’s access to debt capital markets and a robust funding strategy.



While Fidson leads in revenue and PAT, Mecure exhibits a balanced profile of profitability, dividend distribution, and manageable finance costs. Neimeth, despite high revenue growth, remains unprofitable and exposed to FX volatility.







Valuation & Investment Case

• Price-Earnings Ratio (P/E) (Est.): ~19.0x – In line with industry averages

• Dividend Yield: ~1.35% (₦0.15 per ₦11.10 share price)

• Debt Profile: Actively managed through CP issuances with market-reflective discount rates







Key Investment Drivers

1. Strong Earnings Momentum: PAT of ₦2.33bn and revenue growth of 45% YoY demonstrates robust operational efficiency.

2. Strategic Use of Debt Capital: CP programme shows active treasury management and funding agility.

3. Dividend Payment: Indicates shareholder value creation and financial stability.

4. Sector Growth: Nigeria’s healthcare and pharmaceutical sector continues to benefit from increased health spending, import substitution policies, and rising demand for local manufacturing.

5. Institutional Confidence: CP programme expansion and successful issuance point to strong investor trust and liquidity support.







Risks to Outlook

• Rising finance costs (₦4.98 billion) could impact bottom-line margins if not carefully managed.

• Heavy reliance on debt markets for working capital raises leverage concerns, particularly in high-interest environments.

• Macroeconomic risks including FX fluctuations and inflation could affect input costs and consumer demand.







Conclusion



Mecure Industries Plc presents a solid investment opportunity with strong fundamentals, strategic debt management, dividend income potential, and medium-term growth outlook. For investors seeking exposure to Nigeria’s pharmaceutical sector, Mecure offers a compelling mix of value, yield, and expansion capacity.



We assign a BUY recommendation, supported by stable financials, expanding operations, and disciplined capital management.







This recommendation is for informational purposes only and does not constitute investment advice. Investors are encouraged to conduct independent analysis or consult a licensed financial advisor before making any investment decision.

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 2:09pm On May 30, 2025
OMATEK ON FULL BID

InvestmentRe: Nigerian Stock Exchange Market Pick Alerts by SohSoh: 11:33am On May 30, 2025
Executive Summary



Mecure Industries Plc has demonstrated resilient financial performance for the fiscal year 2024/2025, underpinned by strong revenue growth, rising operating profitability, consistent commercial paper issuances, and a dividend payout to shareholders. With a year-on-year (YoY) revenue increase of 45% to ₦46.03 billion and a Profit After Tax (PAT) of ₦2.33 billion, the company remains well-positioned for sustainable expansion within Nigeria’s evolving healthcare landscape.



Given its favorable growth indicators, attractive valuation relative to peers, and continued investor confidence via capital market instruments, we recommend a BUY rating for Mecure Industries Plc.



Strategic Developments & Capital Structure



Mecure Industries has shown disciplined financial stewardship through the issuance of Commercial Paper (CP) to fund working capital and expansion needs. The company expanded its CP programme from ₦20 billion to ₦40 billion, demonstrating its creditworthiness and market confidence. Notable CP issuances include:

• Series 4 (April 2025): ₦9 billion at 22.5468% discount (267-day tenor)

• Series 3 (June 2024): ₦6.5 billion at 23.26%

• Series 2 (Feb 2024): ₦6.03 billion at 18.20%

• Series 1 (Dec 2023): ₦5.12 billion at 16.68%



The cumulative issuance of over ₦26 billion within a 16-month period reinforces the company’s access to debt capital markets and a robust funding strategy.



While Fidson leads in revenue and PAT, Mecure exhibits a balanced profile of profitability, dividend distribution, and manageable finance costs. Neimeth, despite high revenue growth, remains unprofitable and exposed to FX volatility.







Valuation & Investment Case

• Price-Earnings Ratio (P/E) (Est.): ~19.0x – In line with industry averages

• Dividend Yield: ~1.35% (₦0.15 per ₦11.10 share price)

• Debt Profile: Actively managed through CP issuances with market-reflective discount rates







Key Investment Drivers

1. Strong Earnings Momentum: PAT of ₦2.33bn and revenue growth of 45% YoY demonstrates robust operational efficiency.

2. Strategic Use of Debt Capital: CP programme shows active treasury management and funding agility.

3. Dividend Payment: Indicates shareholder value creation and financial stability.

4. Sector Growth: Nigeria’s healthcare and pharmaceutical sector continues to benefit from increased health spending, import substitution policies, and rising demand for local manufacturing.

5. Institutional Confidence: CP programme expansion and successful issuance point to strong investor trust and liquidity support.







Risks to Outlook

• Rising finance costs (₦4.98 billion) could impact bottom-line margins if not carefully managed.

• Heavy reliance on debt markets for working capital raises leverage concerns, particularly in high-interest environments.

• Macroeconomic risks including FX fluctuations and inflation could affect input costs and consumer demand.







Conclusion



Mecure Industries Plc presents a solid investment opportunity with strong fundamentals, strategic debt management, dividend income potential, and medium-term growth outlook. For investors seeking exposure to Nigeria’s pharmaceutical sector, Mecure offers a compelling mix of value, yield, and expansion capacity.



We assign a BUY recommendation, supported by stable financials, expanding operations, and disciplined capital management.







This recommendation is for informational purposes only and does not constitute investment advice. Investors are encouraged to conduct independent analysis or consult a licensed financial advisor before making any investment decision.

1 2 3 4 5 6 (of 6 pages)